Remove 2022 Remove Pharma Remove Prescription
article thumbnail

A realistic view of healthcare in 2022

World of DTC Marketing

1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. People don’t want to lose weight through diet and exercise if they can lose it through a prescription drug.

article thumbnail

Filling the gap—and the prescription—with GoodRx

Fierce Pharma

Filling the gap—and the prescription—with GoodRx. Thu, 11/10/2022 - 18:49.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Top-Performing OTC and Rx Pharma Ads Generated 56 Million Searches in 2022

PM360

Over-the-Counter (OTC) and Prescription (Rx) brands have invested over $3 billion in linear TV advertising during the first half of 2022, with no signs of letting up. Pharma ads generate strong consumer engagement and drive TV viewers to seek additional information online via a search engine such as Google. Impressions.

Pharma 98
article thumbnail

Is pharma being unfairly targeted by the media?

World of DTC Marketing

It’s hard to justify those price increases, but pharma is big business, as all parties in healthcare are. Many people I talk with acknowledge that pharma has been profiteering from drug sales, but they balance that with the need for new drugs to help patients live a better quality of life. million people have died.

Media 205
article thumbnail

Pharma sector reels as UK Government doubles VPAS payback rate on NHS drugs

Pharmaceutical Technology

on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. During 2019–21, when sales being close to predicted levels resulted in single-digit payback rates, the scheme was relatively popular with the pharma sector. billion ($4.1

article thumbnail

Pharma Injecting Life into Digital Health Amidst Funding Downturn

MedCity News

The consensus is 2022 was a challenging year for digital health companies. billion in 2022 — down 56% from $40.2 billion in 2022 — down 56% from $40.2 Rather, 2022 represents an overdue correction in the midst of global economic uncertainty after a period of overexuberance and lofty expectations in digital health.

Pharma 108
article thumbnail

Marketing to Type 2 Diabetes Patients: How Pharma Can Increase Treatment Awareness, Improve Outcomes

PM360

However, despite being one of the biggest markets in pharma, diabetes drugmakers have a hard time standing out in the crowded field, and many patients still aren’t confident in their ability to manage their disease. Patients are willing to explore new prescription therapies as well, but most are unaware of their available options.